Anxiety Disorders Completed Phase 4 Trials for Propranolol (DB00571)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01631682Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders